-
Emicizumab rollout well underway
Montreal, December 16, 2021 – The rollout of emicizumab (Hemlibra) in the provinces and territories served by Canadian Blood Services (CBS) is well underway. Emicizumab...
-
Novel treatments in bleeding disorders: The EHC November Review
CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
-
Hemlibra rollout continues via CBS, more uncertainty in Quebec
November 10, 2021 (Montreal) – The Hemlibra rollout continues in provinces served by Canadian Blood Services (CBS). Since access requests from physicians began to be...
-
CBS announces FVIII and FIX products for 2022-2025
November 3, 2021, Ottawa – Canadian Blood Services (CBS) has announced the results of its Request for Proposals (RFP) to supply recombinant factor VIII and...
-
Children 12 years and under can now access extended half-life FIX in Quebec
October 20, 2021, Montreal – Children 12 years of age and under can now access extended half-life (EHL) factor IX in Quebec for the prophylactic...